Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SB225002
i
Other names:
SB225002, SB 225002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
GSK
Drug class:
CXCR2 antagonist
Related drugs:
‹
SX-682 (2)
AZD5069 (0)
CXCR2 and NGFR transduced TIL (0)
MK-7123 (0)
DF 1681Y (0)
SX-682 (2)
AZD5069 (0)
CXCR2 and NGFR transduced TIL (0)
MK-7123 (0)
DF 1681Y (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCL20 overexpression
Breast Cancer
CCL20 overexpression
Breast Cancer
SB225002
Sensitive: D – Preclinical
SB225002
Sensitive
:
D
SB225002
Sensitive: D – Preclinical
SB225002
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.